Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II-lupus anticoagulant

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 4, 2012, Pages 404-411

  Favaloro, Emmanuel J ^a   Bonar, Roslyn ^b   Marsden, Katherine ^c  

^a WESTMEAD HOSPITAL   (Australia)

^b RCPA Haematology QAP   (Australia)

^c ROYAL HOBART HOSPITAL   (Australia)

Author keywords

antiphospholipid antibodies; antiphospholipid syndrome; external quality assurance; internal quality control; lupus anticoagulant; proficiency testing

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TIME; CONSENSUS; DABOIA RUSSELLII; EXTERNAL QUALITY CONTROL; HUMAN; IMMUNOLOGICAL PROCEDURES; INTERNAL QUALITY CONTROL; KAOLIN CLOTTING TIME; PARTIAL THROMBOPLASTIN TIME; PLATELET NEUTRALIZATION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; PREGNANCY; PREGNANCY COMPLICATIONS; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL;

EID: 84861339901     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1311993     Document Type: Review

References (26)

1. Asherson RA. The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making. Semin Thromb Hemost: 2008; 34 3 227 235
2. Harris EN, Pierangeli SS. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name? Semin Thromb Hemost: 2008; 34 3 219 226
3. Favaloro EJ, Wong RCW. The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? Autoimmunity Highlights: 2010; 1 5 14
4. Favaloro EJ, Wong RC. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med: 2011; 49 3 447 461
5. Miyakis S, Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306
6. Pengo V, Tripodi A, Reber G., et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost: 2009; 7 10 1737 1740
7. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood: 2003; 101 5 1827 1832 (Pubitemid 36237580)
8. Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood: 2003; 102 8 2717 2723 (Pubitemid 37248837)
9. Pengo V, Banzato A, Bison E, Bracco A, Denas G, Ruffatti A. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Semin Thromb Hemost: 2012; 38 4 322 327
10. Galli M. Interpretation and recommended testing for antiphospholipid antibodies. Semin Thromb Hemost: 2012; 38 4 348 352
11. Bonar R, Favaloro EJ, Adcock D. Quality in coagulation and haemostasis testing. Biochem Med: 2010; 20 2 184 199
12. 2- glycoprotein I antibodies. Semin Thromb Hemost: 2012; 38 4 390 403
13. Favaloro EJ, Wong RCW. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey. Pathology: 2009; 41 7 666 675
14. Wong RCW, Gillis D, Adelstein S., et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology: 2004; 36 1 63 68 (Pubitemid 38223415)
15. Wong RC, Favaloro EJ, Adelstein S., et al. Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology: 2008; 40 1 58 63 (Pubitemid 350172955)
16. Wong R, Adelstein S, Gillis D, Favaloro EJ. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost: 2005; 31 1 39 48 (Pubitemid 40262136)
17. Lakos G, Favaloro EJ, Harris EN., et al. International consensus guidelines on anticardiolipin and anti-(2) glycoprotein I testing: report from the 13(th) international congress on antiphospholipid antibodies. Arthritis Rheum: 2012; 64 1 1 10
18. Favaloro EJ, Bonar R, Zebeljan D, Kershaw G, Marsden K. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost: 2010; 8 12 2828 2831
19. Bonar R, Favaloro EJ, Zebeljan D., et al. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP. Pathology: 2012; 44 3 240 247
20. Favaloro EJ, Bonar R, Sioufi J., et al. RCPA QAP in Haematology Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology. Semin Thromb Hemost: 2005; 31 1 49 58 (Pubitemid 40262137)
21. Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology: 1999; 31 2 142 147 (Pubitemid 29264060)
22. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am J Clin Pathol: 2002; 118 4 548 557 (Pubitemid 44698512)
23. Favaloro EJ, Wong RC, Silvestrini R, McEvoy R, Jovanovich S, Roberts-Thomson P. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing. Semin Thromb Hemost: 2005; 31 1 73 84 (Pubitemid 40262140)
24. Favaloro EJ, Wong RCW, Jovanovich S, Roberts-Thomson P. A review of beta2 -glycoprotein-l antibody testing results from a peer-driven multilaboratory quality assurance program. Am J Clin Pathol: 2007; 127 3 441 448 (Pubitemid 46806339)
25. Kershaw G, Suresh S, Orellana D, Nguy Y-M. Laboratory identification of lupus anticoagulants. Semin Thromb Hemost: 2012; 38 4 375 384
26. Tripodi A. To mix or not to mix in lupus anticoagulant testing? That is the question. Semin Thromb Hemost: 2012; 38 4 385 389